ECSP045110A - Composiciones de la preparación que contiene un compuesto fisiologicamente activo de acidos inestables y procesos para su producción - Google Patents

Composiciones de la preparación que contiene un compuesto fisiologicamente activo de acidos inestables y procesos para su producción

Info

Publication number
ECSP045110A
ECSP045110A EC2004005110A ECSP045110A ECSP045110A EC SP045110 A ECSP045110 A EC SP045110A EC 2004005110 A EC2004005110 A EC 2004005110A EC SP045110 A ECSP045110 A EC SP045110A EC SP045110 A ECSP045110 A EC SP045110A
Authority
EC
Ecuador
Prior art keywords
composition
preparation
active compound
production
compositions
Prior art date
Application number
EC2004005110A
Other languages
English (en)
Inventor
Shigeru Aoki
Original Assignee
Eisai Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eisai Co Ltd filed Critical Eisai Co Ltd
Publication of ECSP045110A publication Critical patent/ECSP045110A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846—Poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Abstract

Se tiene la intención de divulgar la composición de la preparación la cual permita la producción conveniente de la composición de la preparación de liberación sostenida que contiene un compuesto activo de ácidos fisiológicamente inestables y tiene las propiedades de liberación sostenida deseada. En especial, la composición de la preparación que comprende un núcleo que contiene un compuesto activo de ácidos fisiológicamente inestables y una capa con la cual el núcleo es revestido y el cual contiene una mezcla de un polímero insoluble en agua y un polímero entérico. La composición de la preparación según la actual invención permite mantener una concentración eficaz en la sangre del compuesto fisiológico activo durante mucho tiempo, mejorando de tal modo su efecto terapéutico. Además, la composición según la actual invención se mantiene estable durante almacenajes prolongados.
EC2004005110A 2001-11-21 2004-05-17 Composiciones de la preparación que contiene un compuesto fisiologicamente activo de acidos inestables y procesos para su producción ECSP045110A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2001356018 2001-11-21

Publications (1)

Publication Number Publication Date
ECSP045110A true ECSP045110A (es) 2004-08-27

Family

ID=19167613

Family Applications (1)

Application Number Title Priority Date Filing Date
EC2004005110A ECSP045110A (es) 2001-11-21 2004-05-17 Composiciones de la preparación que contiene un compuesto fisiologicamente activo de acidos inestables y procesos para su producción

Country Status (25)

Country Link
EP (1) EP1454634A4 (es)
JP (1) JP4540092B2 (es)
KR (1) KR20050044545A (es)
CN (2) CN101982199A (es)
AP (1) AP1919A (es)
AU (1) AU2002366029B2 (es)
BR (1) BR0214372A (es)
CA (1) CA2466726C (es)
CO (1) CO5580800A2 (es)
CR (1) CR7351A (es)
EC (1) ECSP045110A (es)
HU (1) HUP0402323A3 (es)
IL (2) IL161983A0 (es)
IS (1) IS7266A (es)
MA (1) MA26346A1 (es)
MX (1) MXPA04004775A (es)
NO (1) NO20042563L (es)
NZ (1) NZ532907A (es)
RO (1) RO122395B1 (es)
RU (1) RU2311906C2 (es)
SI (1) SI21447A (es)
TW (1) TWI302461B (es)
UA (1) UA76256C2 (es)
WO (1) WO2003043661A1 (es)
ZA (1) ZA200403551B (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8071128B2 (en) 1996-06-14 2011-12-06 Kyowa Hakko Kirin Co., Ltd. Intrabuccally rapidly disintegrating tablet and a production method of the tablets
CN1938026A (zh) * 2004-03-26 2007-03-28 卫材R&D管理有限公司 控释制剂及其制造方法
US8747895B2 (en) 2004-09-13 2014-06-10 Aptalis Pharmatech, Inc. Orally disintegrating tablets of atomoxetine
US9884014B2 (en) 2004-10-12 2018-02-06 Adare Pharmaceuticals, Inc. Taste-masked pharmaceutical compositions
CA2584957C (en) 2004-10-21 2015-08-25 Eurand Pharmaceuticals Limited Taste-masked pharmaceutical compositions with gastrosoluble pore-formers
CA2592605C (en) 2004-12-27 2010-12-07 Eisai R&D Management Co., Ltd. Method for stabilizing anti-dementia drug
WO2006123364A2 (en) * 2005-03-14 2006-11-23 Sun Pharmaceutical Industries Limited Oral drug delivery system providing a coating comprising both a cellulose and a methacrylic acid derivative
WO2006111853A2 (en) * 2005-04-18 2006-10-26 Aurobindo Pharma Limited Stable solid dosage forms of acid labile drug
US9161918B2 (en) 2005-05-02 2015-10-20 Adare Pharmaceuticals, Inc. Timed, pulsatile release systems
WO2008062320A2 (en) 2006-10-06 2008-05-29 Eisai R&D Management Co., Ltd Extended release formulations of a proton pump inhibitor
WO2009069280A1 (ja) * 2007-11-27 2009-06-04 Ohara Pharmaceutical Co., Ltd. 造粒物の製造法
CN101822671A (zh) * 2009-03-06 2010-09-08 信谊药厂 雷贝拉唑组合物及其制备方法
WO2011067667A2 (en) 2009-12-02 2011-06-09 Eurand Pharmaceuticals Limited Fexofenadine microcapsules and compositions containing them
NZ605562A (en) * 2010-07-09 2013-11-29 Teijin Pharma Ltd Deuterated benzylbenzene derivatives and methods of use
JP2018184360A (ja) * 2017-04-25 2018-11-22 ニプロ株式会社 経口投与用の腸溶性徐放性製剤
KR102227486B1 (ko) * 2017-06-30 2021-03-12 롯데정밀화학 주식회사 프로톤 펌프 저해제를 포함하는 경구용 고형제제 조성물, 이를 포함하는 경구용 고형제제 및 그 제조방법

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2336218C3 (de) * 1973-07-17 1985-11-14 Byk Gulden Lomberg Chemische Fabrik Gmbh, 7750 Konstanz Orale Arzneiform
JPS5944311A (ja) * 1982-09-07 1984-03-12 Santen Pharmaceut Co Ltd 徐放性顆粒およびその製造法
ATE124864T1 (de) * 1989-03-10 1995-07-15 Yamanouchi Pharma Co Ltd Die wirkstoffabgabe steuerndes überzugsmaterial für lang wirksame formulierungen.
EP0447168A3 (en) * 1990-03-16 1993-01-07 Yamanouchi Pharmaceutical Co. Ltd. Long acting granular pharmaceutical composition
JPH0826977A (ja) * 1994-07-19 1996-01-30 Tanabe Seiyaku Co Ltd 溶出制御型経口製剤
JPH09323926A (ja) * 1996-03-15 1997-12-16 Nikken Chem Co Ltd バルプロ酸ナトリウムの徐放性錠剤
ES2137862B1 (es) * 1997-07-31 2000-09-16 Intexim S A Preparacion farmaceutica oral que comprende un compuesto de actividad antiulcerosa y procedimiento para su obtencion.
WO1999053918A1 (fr) * 1998-04-20 1999-10-28 Eisai Co., Ltd. Compositions stabilisees contenant des composes du type benzimidazole
DK1736144T3 (en) * 1998-05-18 2015-12-07 Takeda Pharmaceutical Orally disintegrating tablets.
JP2001055322A (ja) * 1999-08-18 2001-02-27 Tanabe Seiyaku Co Ltd パルス放出型製剤
DK1222922T3 (da) * 1999-10-20 2007-12-03 Eisai R&D Man Co Ltd Fremgangsmåde til stabilisering af benzimidazolforbindelser
US6627223B2 (en) * 2000-02-11 2003-09-30 Eurand Pharmaceuticals Ltd. Timed pulsatile drug delivery systems

Also Published As

Publication number Publication date
KR20050044545A (ko) 2005-05-12
TWI302461B (en) 2008-11-01
EP1454634A1 (en) 2004-09-08
CO5580800A2 (es) 2005-11-30
RU2004118495A (ru) 2005-03-20
NO20042563L (no) 2004-06-18
NZ532907A (en) 2007-05-31
AU2002366029B2 (en) 2008-01-31
CN101982199A (zh) 2011-03-02
WO2003043661A1 (fr) 2003-05-30
BR0214372A (pt) 2004-10-26
CN1589156A (zh) 2005-03-02
AU2002366029A1 (en) 2003-06-10
IS7266A (is) 2004-05-14
CA2466726A1 (en) 2003-05-30
UA76256C2 (en) 2006-07-17
RU2311906C2 (ru) 2007-12-10
MXPA04004775A (es) 2005-02-17
RO122395B1 (ro) 2009-05-29
AP1919A (en) 2008-11-13
AP2004003045A0 (en) 2004-06-30
JPWO2003043661A1 (ja) 2005-03-10
TW200300353A (en) 2003-06-01
EP1454634A4 (en) 2007-05-30
JP4540092B2 (ja) 2010-09-08
ZA200403551B (en) 2005-07-07
SI21447A (sl) 2004-10-31
HUP0402323A3 (en) 2008-04-28
CR7351A (es) 2005-05-12
CA2466726C (en) 2011-02-22
MA26346A1 (fr) 2004-10-01
IL161983A0 (en) 2005-11-20
HUP0402323A2 (hu) 2005-02-28
IL161983A (en) 2009-11-18

Similar Documents

Publication Publication Date Title
ECSP045110A (es) Composiciones de la preparación que contiene un compuesto fisiologicamente activo de acidos inestables y procesos para su producción
DE602005021770D1 (de) Indol-1-yl-essigsäurederivate
BRPI0014869B8 (pt) prostaglandinas bicíclicas, composições estabilizadas das mesmas, bem como processo para sua estabilização
CR6656A (es) Forma de dosificacion de farmacos accionada por un hidrogel
AR109263A2 (es) Composición que comprende moxidectina
AR037490A1 (es) Composiciones farmaceuticas solidas, proceso para su preparacion, kit para el tratamiento de la obesidad y uso de dichas composiciones en la elaboracion de medicamentos
RU2013121788A (ru) Ингибиторы репликации вич
AR042340A1 (es) Liberacion controlada de una sustancia activa a un entorno rico en grasa
UY29410A1 (es) Composiciones farmacéuticas en base a metilamidas del ácido 4-(4-/-3(-4-cloro-3-trifluorometifenil)ureido)fenoxi)piridin-2-carboxílico, procedimiento de preparación y aplicaciones.
PA8575701A1 (es) Preparaciones acidas de insulina con estabilidad mejorada
PE20090605A1 (es) Composiciones de fenilalanina amoniaco-liasa procariotica y metodos del tratamiento del cancer usando composiciones de la misma
TNSN05189A1 (en) Medium-chain length fatty acids, glycerides and analogues as stimulators of erythropoiesis
CY1108992T1 (el) Η χρηση του υαλουρονικου οξεος για την παρασκευη συνθεσεων για τη θεραπευτικη αντιμετωπιση υποτροπιαζουσων αφθων της στοματικης κοιλοτητας
AR034900A1 (es) Uso de una cantidad eficaz de un inhibidor de pde4 y un agente anticolinergico, bien en forma combinada sola o por separado, composiciones farmaceuticas que los comprenden, metodo para prepararlas, y uso de una composicion que comprende una cantidad eficaz de un inhibidor de pde4, una cantidad efica
AR038141A1 (es) Composiciones farmaceuticas estables que comprenden inhibidor(es) de ace
DE60123100D1 (de) Honig enthaltende pharmazeutische zusammensetzung zur wundbehandlung
DK1377164T3 (da) Erythropoietin forbedrer kemoterapi-induceret toksicitet in vivo
AR006892A1 (es) Uso de formas del acido hialuronico (ha) para el tratamiento del cancer
AR063894A1 (es) Uso de un acido indazolmetoxialcanoico para preparar una composicion farmaceutica
UY32644A (es) Compuesto anticancerígeno y composición farmacéutica que lo contiene
SE0000303D0 (sv) Novel compounds
AR038632A1 (es) Composicion farmaceutica
BR0214487A (pt) Composição farmacêutica que compreende uma combinação de metformina e um ácido 4-oxobutanóico, e o uso da mesma para o tratamento de diabetes
JP2006160607A5 (es)
BR0302470A (pt) Composições antiácidas lìquidas